Finke C - Search Results

1

Circulating levels of MCP-1, sIL-2R, IL-15, and IL-8 predict anemia response to pomalidomide therapy in myelofibrosis.

Pardanani A, Begna K, Finke C, Lasho T, Tefferi A. Pardanani A, et al. Among authors: finke c. Am J Hematol. 2011 Apr;86(4):343-5. doi: 10.1002/ajh.21972. Am J Hematol. 2011. PMID: 21442636 Free article. Clinical Trial.

2

Clinical correlates of JAK2V617F allele burden in essential thrombocythemia.

Kittur J, Knudson RA, Lasho TL, Finke CM, Gangat N, Wolanskyj AP, Li CY, Wu W, Ketterling RP, Pardanani A, Tefferi A. Kittur J, et al. Cancer. 2007 Jun 1;109(11):2279-84. doi: 10.1002/cncr.22663. Cancer. 2007. PMID: 17440984 Free article.

3

Extending Jak2V617F and MplW515 mutation analysis to single hematopoietic colonies and B and T lymphocytes.

Pardanani A, Lasho TL, Finke C, Mesa RA, Hogan WJ, Ketterling RP, Gilliland DG, Tefferi A. Pardanani A, et al. Among authors: finke c. Stem Cells. 2007 Sep;25(9):2358-62. doi: 10.1634/stemcells.2007-0175. Epub 2007 May 31. Stem Cells. 2007. PMID: 17540852

4

Cytogenetic studies at diagnosis in polycythemia vera: clinical and JAK2V617F allele burden correlates.

Gangat N, Strand J, Lasho TL, Finke CM, Knudson RA, Pardanani A, Li CY, Ketterling RP, Tefferi A. Gangat N, et al. Eur J Haematol. 2008 Mar;80(3):197-200. doi: 10.1111/j.1600-0609.2007.01003.x. Epub 2007 Dec 7. Eur J Haematol. 2008. PMID: 18081705

5

Oligonucleotide array CGH studies in myeloproliferative neoplasms: comparison with JAK2V617F mutational status and conventional chromosome analysis.

Tefferi A, Sirhan S, Sun Y, Lasho T, Finke CM, Weisberger J, Bale S, Compton J, LeDuc CA, Pardanani A, Thorland EC, Shevchenko Y, Grodman M, Chung WK. Tefferi A, et al. Among authors: finke cm. Leuk Res. 2009 May;33(5):662-4. doi: 10.1016/j.leukres.2008.09.009. Epub 2008 Oct 19. Leuk Res. 2009. PMID: 18937974

6

Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors.

Lim KH, Tefferi A, Lasho TL, Finke C, Patnaik M, Butterfield JH, McClure RF, Li CY, Pardanani A. Lim KH, et al. Among authors: finke c. Blood. 2009 Jun 4;113(23):5727-36. doi: 10.1182/blood-2009-02-205237. Epub 2009 Apr 10. Blood. 2009. PMID: 19363219 Free article.

7

Prognostically relevant breakdown of 123 patients with systemic mastocytosis associated with other myeloid malignancies.

Pardanani A, Lim KH, Lasho TL, Finke C, McClure RF, Li CY, Tefferi A. Pardanani A, et al. Among authors: finke c. Blood. 2009 Oct 29;114(18):3769-72. doi: 10.1182/blood-2009-05-220145. Epub 2009 Aug 27. Blood. 2009. PMID: 19713463 Free article. Clinical Trial.

8

WHO subvariants of indolent mastocytosis: clinical details and prognostic evaluation in 159 consecutive adults.

Pardanani A, Lim KH, Lasho TL, Finke CM, McClure RF, Li CY, Tefferi A. Pardanani A, et al. Blood. 2010 Jan 7;115(1):150-1. doi: 10.1182/blood-2009-10-249979. Blood. 2010. PMID: 20056798 Free article. No abstract available.

9

Circulating interleukin (IL)-8, IL-2R, IL-12, and IL-15 levels are independently prognostic in primary myelofibrosis: a comprehensive cytokine profiling study.

Tefferi A, Vaidya R, Caramazza D, Finke C, Lasho T, Pardanani A. Tefferi A, et al. Among authors: finke c. J Clin Oncol. 2011 Apr 1;29(10):1356-63. doi: 10.1200/JCO.2010.32.9490. Epub 2011 Feb 7. J Clin Oncol. 2011. PMID: 21300928

10

Isolated del(5q) in myeloid malignancies: clinicopathologic and molecular features in 143 consecutive patients.

Patnaik MM, Lasho TL, Finke CM, Knudson RA, Ketterling RP, Chen D, Hoyer JD, Hanson CA, Tefferi A. Patnaik MM, et al. Am J Hematol. 2011 May;86(5):393-8. doi: 10.1002/ajh.21984. Am J Hematol. 2011. PMID: 21523797 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

390 results

Search Page

Filters